Bacterial inhibition of Fas-mediated killing promotes neuroinvasion and persistence

被引:0
|
作者
Claire Maudet
Marouane Kheloufi
Sylvain Levallois
Julien Gaillard
Lei Huang
Charlotte Gaultier
Yu-Huan Tsai
Olivier Disson
Marc Lecuit
机构
[1] Biology of Infection Unit,Institut Pasteur, Université de Paris, Inserm U1117
[2] National Reference Center and WHO Collaborating Center Listeria,Institut Pasteur
[3] APHP,Necker
[4] Institut Imagine,Enfants Malades University Hospital, Division of Infectious Diseases and Tropical Medicine
[5] National Yang-Ming University,Institute of Microbiology and Immunology
来源
Nature | 2022年 / 603卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Infections of the central nervous system are among the most serious infections1,2, but the mechanisms by which pathogens access the brain remain poorly understood. The model microorganism Listeria monocytogenes (Lm) is a major foodborne pathogen that causes neurolisteriosis, one of the deadliest infections of the central nervous system3,4. Although immunosuppression is a well-established host risk factor for neurolisteriosis3,5, little is known about the bacterial factors that underlie the neuroinvasion of Lm. Here we develop a clinically relevant experimental model of neurolisteriosis, using hypervirulent neuroinvasive strains6 inoculated in a humanized mouse model of infection7, and we show that the bacterial surface protein InlB protects infected monocytes from Fas-mediated cell death by CD8+ T cells in a manner that depends on c-Met, PI3 kinase and FLIP. This blockade of specific anti-Lm cellular immune killing lengthens the lifespan of infected monocytes, and thereby favours the transfer of Lm from infected monocytes to the brain. The intracellular niche that is created by InlB-mediated cell-autonomous immune resistance also promotes Lm faecal shedding, which accounts for the selection of InlB as a core virulence gene of Lm. We have uncovered a specific mechanism by which a bacterial pathogen confers an increased lifespan to the cells it infects by rendering them resistant to cell-mediated immunity. This promotes the persistence of Lm within the host, its dissemination to the central nervous system and its transmission.
引用
收藏
页码:900 / 906
页数:6
相关论文
共 50 条
  • [1] Bacterial inhibition of Fas-mediated killing promotes neuroinvasion and persistence
    Maudet, Claire
    Kheloufi, Marouane
    Levallois, Sylvain
    Gaillard, Julien
    Huang, Lei
    Gaultier, Charlotte
    Tsai, Yu-Huan
    Disson, Olivier
    Lecuit, Marc
    NATURE, 2022, 603 (7903) : 900 - +
  • [2] The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
    OConnell, J
    OSullivan, GC
    Collins, JK
    Shanahan, F
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03): : 1075 - 1082
  • [3] Inhibition of Fas-mediated apoptosis by antigen: Implications for lymphomagenesis
    Schattner, EJ
    Friedman, SM
    Casali, P
    AUTOIMMUNITY, 2002, 35 (04) : 283 - 289
  • [4] Inhibition of Fas-mediated apoptosis by Trypanosoma cruzi infection
    Nakajima-Shimada, J
    Zou, CB
    Takagi, M
    Umeda, M
    Nara, T
    Aoki, T
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2000, 1475 (02): : 175 - 183
  • [5] Fas-mediated apoptosis
    Nagata, S
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VI: CELL CYCLE AND PROGRAMMED CELL DEATH IN THE IMMUNE SYSTEM, 1996, 406 : 119 - 124
  • [6] FAS-MEDIATED APOPTOSIS
    NAGATA, S
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 795 - 795
  • [7] Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel
    Symes, Juliane C.
    Kurin, Michael
    Fleshner, Neil E.
    Medin, Jeffrey A.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) : 3018 - 3028
  • [8] Inhibition of Fas-mediated apoptosis in lymphoma cells by antigen.
    Schattner, EJ
    Mascarenhas, JO
    Friedman, SM
    Casali, P
    BLOOD, 1997, 90 (10) : 613 - 613
  • [9] Autocrine secretion of fas ligand shields tumor cells from fas-mediated killing by cytotoxic lymphocytes
    Hallermalm, K
    De Geer, A
    Kiessling, R
    Levitsky, V
    Levitskaya, J
    CANCER RESEARCH, 2004, 64 (18) : 6775 - 6782
  • [10] Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras
    Fenton, RG
    Hixon, JA
    Wright, PW
    Brooks, AD
    Sayers, TJ
    CANCER RESEARCH, 1998, 58 (15) : 3391 - 3400